Searched for
SPANISH DRUG MAKER
Europe must shape up or will lose to US and China, say CEOsBusiness leaders at the World Economic Forum are sounding an alarm for Europe. They warn that excessive rules and slow processes are hinder...- European shares rise as Inditex leads retailers, Novo Nordisk shinesEuropean shares experienced a rise, propelled by strong performances in the retail sector, particularly Inditex, which reported accelerated...
- Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMTMorgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias...
- Intas in pact with Spanish drug maker mAbxience to sell biosimilar etanercept in over 150 countriesmAbxience, a majority-owned company of German drug maker Fresenius Kabi, also has partial ownership from Insud Pharma, will be responsible ...
- Stocks in the news: Vodafone Idea, Tata Steel, Sun Pharma, Adani Transmission & ZEELIndia Ratings and Research (Ind-Ra) said it has upgraded Tata Steel's long-term issuer rating to 'AA+' from 'AA'.
- Glenmark looks to license out second drug assetGlenmark chairman and managing director Glenn Saldanha said one of the corporate objectives of the Mumbai-headquartered company is to do at...
- Trump's Covid 'gamechanger' hydroxychloroquine turns life-changer for an obscure Indian plantationDonald Trump vowed in March to make the affordable medication widely available to fight the pandemic, which has sickened about 2 million pe...
- MCX, Sun Pharma, PNB Housing and Strides Pharma among stocks in the newsHere's a look at the top stocks that may hog the limelight in today's session.
- Sun marches ahead with its specialty pipeline, announces European approval for TildraIn the last two months Sun Pharma has received approval for four drugs from its pipeline after a dry spell of nearly 2 years.
- Tildra approval to give sentimental push to Sun PharmaThe drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune ...
- Sun Pharmaceutical signs agreement with Samsung BioLogics for psoriasis drugThe novel drug known as Tildrakizumab is currently under review by the US FDA and the European Medicines Agency (EMA). The value of the con...
- Sun Pharma signs licening pact with spanish firm Almirall for psoriasis drugIn return, the Indian company will receive an initial upfront payment of $50 million and be eligible for development and regulatory milesto...
- Fifteen stocks in focus in Monday morning tradeThe Indian market is expected to open lower. Here is a list of top fifteen stocks that are likely to be in focus today.
- Britons are behaving badly abroad: UK govtSpain is the choice for millions of British travellers, but more and more British citizens are spending time in Spanish jails. Top 10 beach...
- Zydus Cadila buys Spain's Laboratories CombixDrug maker Zydus Cadila on Friday announced its foray into Spain, the fifth largest pharmaceutical market in the world.
- Zydus Cadila forays into Spain; acquires Laboratories CombixDrug maker Zydus Cadila announced its foray into Spain, the fifth largest pharmaceutical market in the world, through the acquisition of La...
- Outlicensing deals a leg up for drug researchRecent drug outlicensing deals by Indian pharma companies have created much hope for research initiatives in the country.
- Cos exit generics for core focusAs international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
- Wanbury acquires Spanish drugmaker for Rs 240 crWanbury on Monday said it has agreed to acquire Spanish drugmaker Industria Farmaceutica Cantabri’s branded generic business for Rs 240 cro...
- Ranbaxy acquires GSK's generics business in SpainRanbaxy Laboratories said it has acquired Anglo-American drug maker GlaxoSmithKline’s Mundogen generic business in Spain for an undisclosed...
Load More
